Our findings indicated that ASP-RNAi-mediated silencing of disease-causing EGFR alleles specifically inhibited the proliferation of human cancer cells carrying the oncogenic alleles, but did not affect normal cells or tissues that had no target oncogenic allele in vivo. The gene discussed is EGFR; the disease is cancer.